CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...
Phase 3
Portland, Oregon, United States and 18 other locations
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Portland, Oregon, United States and 72 other locations
feasibility of a stationary aerobic cycling intervention and explore if aerobic exercise independently promotes remyelination in people with multiple...
Phase 1, Phase 2
Portland, Oregon, United States
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Portland, Oregon, United States and 208 other locations
The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple...
Phase 1
Portland, Oregon, United States and 34 other locations
relapse rate (ARR) in participants with relapsing forms of MSSecondary Objective:To assess efficacy of SAR442168 compared to teriflunomide (...
Phase 3
Portland, Oregon, United States and 178 other locations
A study to evaluate the efficacy and safety of fenebrutinib on disability progression in adult participants with Primary Progressive Multiple...
Phase 3
Portland, Oregon, United States and 192 other locations
Primary Objective:To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple...
Phase 3
Portland, Oregon, United States and 291 other locations
) neo-antigen in subjects with relapsing multiple sclerosis (RMS)....
Phase 3
Portland, Oregon, United States and 301 other locations
Primary Objective:To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in NRSPMSSecondary Objective:To evalu...
Phase 3
Portland, Oregon, United States and 300 other locations
Clinical trials
Research sites
Resources
Legal